Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1999-11-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.96.24.14136PMID 10570211PMCID PMC24203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of the cannabinoid receptor agonist WIN55212‐2 on sympathetic cardiovascular regulation

  1999cited by this paper
• Mesenteric vasodilation mediated by endothelial anandamide receptors.

  1999cited by this paper
• Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

  1999cited by this paper
• Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

  1999cited by this paper
• Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current.

  1999cited by this paper
• Anandamide‐induced mobilization of cytosolic Ca2+ in endothelial cells

  1999cited by this paper
• Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

  1999cited by this paper
• Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release.

  1999cited by this paper
• K+ is an endothelium-derived hyperpolarizing factor in rat arteries

  1998cited by this paper
• The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery

  1998cited by this paper
• Endocannabinoids: a new class of vasoactive substances.

  1998cited by this paper
• Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator?

  1998cited by this paper
• Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

  1998cited by this paper
• Cardiovascular actions of cannabinoids and their generation during shock

  1998cited by this paper
• Interactions between synthetic vanilloids and the endogenous cannabinoid system

  1998cited by this paper
• Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat

  1997cited by this paper
• Production and physiological actions of anandamide in the vasculature of the rat kidney.

  1997cited by this paper
• A comparison of EDHF‐mediated and anandamide‐induced relaxations in the rat isolated mesenteric artery

  1997cited by this paper
• Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats.

  1997cited by this paper
• Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.

  1997cited by this paper
• Characterization and modulation of EDHF‐mediated relaxations in the rat isolated superior mesenteric arterial bed

  1997cited by this paper
• Role of potassium channels in endothelium‐dependent relaxation resistant to nitroarginine in the rat hepatic artery

  1996cited by this paper
• Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB 1 receptors on peripheral sympathetic nerves

  1996cited by this paper
• Mechanism of the hypotensive action of anandamide in anesthetized rats.

  1996cited by this paper
• Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats

  1996cited by this paper
• Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

  1996cited by this paper
• Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats.

  1996cited by this paper
• Cardiovascular effects of (−)-11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl in rats

  1996cited by this paper
• An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*)

  1995cited by this paper
• Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

  1995cited by this paper
• Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.

  1995cited by this paper
• (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability.

  1994cited by this paper
• Formation and inactivation of endogenous cannabinoid anandamide in central neurons

  1994cited by this paper
• The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

  1994cited by this paper
• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  1994cited by this paper
• Molecular characterization of a peripheral receptor for cannabinoids

  1993cited by this paper
• Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

  1993cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Stimulus-secretion coupling in vascular endothelial cells.

  1990cited by this paper
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA

  1990cited by this paper
• Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor.

  1990cited by this paper
• Cannabinoid pharmacology.

  1986cited by this paper
• A cannabinoid with cardiovascular activity but no overt behavioral effects

  1977cited by this paper
• Hashish. A simple one-step synthesis of (-)-delta1-tetrahydrocannabinol (THC) from p-mentha-2,8-dien-1-ol and olivetol.

  1974cited by this paper
• Role of the central autonomic nervous system in the hypotension and bradycardia induced by (‐)‐Δ9‐trans‐tetrahydrocannabinol

  1974cited by this paper
• Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol.

  1974cited by this paper

• Neuroglia in substance use disorders.

  2025cites this paper
• Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery

  2025cites this paper
• Nonclassical Cannabinoid Receptors: Modern Concepts of Signal Transmission Functions and Mechanisms

  2025cites this paper
• Single oral administration of dronabinol increases ocular blood flow in patients with glaucoma

  2025cites this paper
• Chemical profile and bioactive properties of Cannabis sativa threshing residue: Vasorelaxant, antioxidant, immunomodulatory, and antibacterial activities

  2024cites this paper
• Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation

  2024cites this paper
• Role of Cannabinoids in Oral Cancer

  2024cites this paper
• Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

  2023cites this paper
• Anxiety Modulation by Cannabinoids—The Role of Stress Responses and Coping

  2023cites this paper
• Pharmacognosy and Effects of Cannabinoids in the Vascular System.

  2022cites this paper
• Acute and long-term effects of cannabinoids on hypertension and kidney injury

  2022cites this paper
• The endocannabinoid anandamide is an airway relaxant in health and disease

  2022cites this paper
• Nationwide Trends in Hospitalizations and Outcomes of Pulmonary Circulation Disorders Among Patients With Cannabis Use Disorder in the United States

  2022cites this paper
• Cannabinoid receptors are expressed in equine synovium and upregulated with synovitis.

  2022cites this paper
• Inactivation of fatty acid amide hydrolase protects against ischemic reperfusion injury-induced renal fibrogenesis.

  2022cites this paper
• Endocannabinoids and related compounds as modulators of angiogenesis: Concepts and clinical significance

  2022cites this paper
• GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries

  2022cites this paper
• Characterization of hypotensive and vasorelaxant effects of PHAR-DBH-Me a new cannabinoid receptor agonist

  2022cites this paper
• A molecular explanation of cardiovascular protection through abnormal cannabidiol: Involving the dysfunctional β‐adrenergic and ATP‐sensitive K+ channel activity in cardiovascular compromised preterm infants

  2021cites this paper
• Endocannabinoid signaling pathways: beyond CB1R and CB2R

  2021cites this paper
• Genetic deletion of the cannabinoid receptors CB1 and CB2 enhances inflammation with diverging effects on skin wound healing in mice.

  2021cites this paper
• Cannabidiol safety

  2021cites this paper
• Immunohistochemical expression of cannabinoid receptors in women's cancers: what's new?

  2021cites this paper
• Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression

  2021cites this paper
• The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects

  2021cites this paper
• Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils

  2021cites this paper
• A study of abnormal cannabidiols system‐mediated cardiovascular protection in disrupted gut/brain axis associated depression

  2021cites this paper
• Beyond THC and Endocannabinoids.

  2020cites this paper
• Roles of G protein-coupled receptors in inflammatory bowel disease

  2020cites this paper
• Effects of Oleamide on the Vasomotor Responses in the Rat

  2020cites this paper
• Pregnancy success in mice requires appropriate cannabinoid receptor signaling for primary decidua formation

  2020cites this paper
• Abnormal Cannabidiol Affects Production of Pro-Inflammatory Mediators and Astrocyte Wound Closure in Primary Astrocytic-Microglial Cocultures

  2020cites this paper
• Acute rimonabant treatment promotes protein synthesis in C2C12 myotubes through a CB1‐independent mechanism

  2020cites this paper
• Characterization of Novel CB2 Agonist SMM-295 and Its Effects in Ischemia/Reperfusion Injury

  2020cites this paper
• Prediction of the binding affinities and selectivity for CB1 and CB2 ligands using homology modeling, molecular docking, molecular dynamics simulations, and MM-PBSA binding free energy calculations.

  2020cites this paper
• Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health

  2020cites this paper
• The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease

  2020cites this paper
• The molecular mechanisms that underpin the biological benefit of full spectrum cannabis extract in the treatment of neuropathic pain and inflammation.

  2020cites this paper
• Cannabinoid-sensitive receptors in cardiac physiology and ischaemia.

  2020cites this paper
• Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure

  2020influential citation
• CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A)

  2020cites this paper
• The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease

  2020cites this paper
• CB1 and LPA1 Receptors Relationship in the Mouse Central Nervous System

  2019cites this paper
• Biological bases for a possible effect of cannabidiol in Parkinson’s disease

  2019cites this paper
• Cannabinoids and Cardiovascular System.

  2019cites this paper
• Diet‐Induced Obesity in Cannabinoid‐2 Receptor Knockout Mice and Cannabinoid Receptor 1/2 Double‐Knockout Mice

  2019cites this paper
• Caffeine Exacerbates Postictal Hypoxia.

  2019cites this paper
• Abnormal Cannabidiol Modulates Vitamin A Metabolism by Acting as a Competitive Inhibitor of CRBP1.

  2019cites this paper
• Mice Missing Cnr1 and Cnr2 Show Implantation Defects.

  2019cites this paper
• Understanding cannabinoid receptors: structure and function

  2019cites this paper
• Cannabinoids, interoception, and anxiety.

  2019cites this paper
• Pharmacological and second messenger-mediated modulation of heterologously expressed and neuronal calcium-dependent potassium currents

  2019cites this paper
• Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects

  2019cites this paper
• Opposite Effects of Neuroprotective Cannabinoids, Palmitoylethanolamide, and 2-Arachidonoylglycerol on Function and Morphology of Microglia

  2019cites this paper
• Aging circadian rhythms and cannabinoids.

  2019cites this paper
• LH‐21 and abnormal cannabidiol improve β‐cell function in isolated human and mouse islets through GPR55‐dependent and ‐independent signalling

  2018cites this paper
• Biotin conjugated organic molecules and proteins for cancer therapy: A review.

  2018cites this paper
• The quest for endothelial atypical cannabinoid receptor: BKCa channels act as cellular sensors for cannabinoids in in vitro and in situ endothelial cells.

  2018influential citation
• The endocannabinoid system in cardiovascular function: novel insights and clinical implications

  2018cites this paper
• Investigation of non-CB1, non-CB2 WIN55212-2-sensitive G-protein-coupled receptors in the brains of mammals, birds, and amphibians

  2018cites this paper
• Perioperative implications of common and newer psychotropic medications used in clinical practice.

  2018cites this paper
• Endocannabinoid-mediated modulation of Gq protein-coupled receptor mediates vascular hyporeactivity to nor-adrenaline during polymicrobial sepsis

  2018cites this paper
• The role of the endocannabinoid system in preterm birth

  2018cites this paper
• Molecular and functional interaction between GPR18 and cannabinoid CB2 G‐protein‐coupled receptors. Relevance in neurodegenerative diseases

  2018cites this paper
• Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.

  2018cites this paper
• Understanding cannabinoid receptors: structure and function

  2018cites this paper
• The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats

  2017cites this paper
• The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.

  2017cites this paper
• The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA‐salt hypertensive rats

  2017cites this paper
• Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors.

  2017cites this paper
• Cannabinoid receptor 1/2 double‐knockout mice develop epilepsy

  2017cites this paper
• Cannabinoids in the Cardiovascular System.

  2017cites this paper
• Cannabis: A Treasure Trove or Pandora's Box?

  2017cites this paper
• Coronary vasospasm complicating cannabinoid hyperemesis syndrome.

  2017cites this paper
• Direct activation of Ca2+ and voltage‐gated potassium channels of large conductance by anandamide in endothelial cells does not support the presence of endothelial atypical cannabinoid receptor

  2017cites this paper
• Chapter 2 – Cannabinoid Receptors and Their Signaling Mechanisms

  2017cites this paper
• Cannabinoids Regulate the Diameter of Pericyte-Containing Retinal Capillaries in Rats

  2017cites this paper
• Pharmacological inhibition of FAAH activity in rodents: A promising pharmacological approach for psychological—cardiac comorbidity?

  2017cites this paper
• ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BK_Ca channels, and nitric oxide dependent mechanisms

  2017cites this paper
• G protein coupled receptor 18: A potential role for endocannabinoid signaling in metabolic dysfunction.

  2016cites this paper
• Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists

  2016cites this paper
• Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools.

  2016cites this paper
• Ligands for cannabinoid receptors, promising anticancer agents.

  2016cites this paper
• The Orphan Nuclear Receptor ERRγ Regulates Hepatic CB1 Receptor-Mediated Fibroblast Growth Factor 21 Gene Expression

  2016cites this paper
• Chemical probes for the study of the endogenous cannabinoid system

  2016cites this paper
• Is the cardiovascular system a therapeutic target for CBD ?

  2016cites this paper
• Intracoronary thrombus in an 18-year-old teenager. Why?

  2016cites this paper
• Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment

  2016influential citation
• The cannabinoid system and its role in nociception

  2016cites this paper
• Endocannabinoids in cerebrovascular regulation.

  2016cites this paper
• The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries

  2016cites this paper
• Effects of activation of endocannabinoid system on myocardial metabolism.

  2016cites this paper
• From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology.

  2016influential citation
• EFFECT OF MARIJUANA ON THE CENTRAL NERVOUS SYSTEM

  2016cites this paper
• infusion in conscious rats regional hemodynamic responses to lipopolysaccharide

  2016cites this paper
• Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors

  2016cites this paper
• Effekte des Endocannabinoidrezeptors CB2 auf die myokardiale Protektion

  2016cites this paper
• The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia.

  2016cites this paper
• New synthetic cannabinoid intoxications in emergency department (It's grass, it's no sin)

  2016cites this paper
• The Role for the Endocannabinoid System in Cardioprotection and Myocardial Adaptation

  2016cites this paper